Once-weekly basal insulin icodec: Looking ONWARDS from pharmacology to clinical trials

Switching to Once-Weekly Insulin Icodec Versus Once-Daily Insulin Glargine U100 in Type 2 Diabetes Inadequately Controlled on Daily Basal Insulin: A Phase 2 Randomized Controlled Trial

(2021) Harpreet S. Bajaj et al.   DIABETES CARE

A Randomized, Open-Label Comparison of Once-Weekly Insulin Icodec Titration Strategies Versus Once-Daily Insulin Glargine U100

(2021) Ildiko Lingvay et al.   DIABETES CARE

Molecular Engineering of Insulin Icodec, the First Acylated Insulin Analog for Once-Weekly Administration in Humans

(2021) Thomas B. Kjeldsen et al.   JOURNAL OF MEDICINAL CHEMISTRY

Icodec Advances the Prospect of Once-Weekly Insulin Injection

(2021) Richard D. DiMarchi et al.   JOURNAL OF MEDICINAL CHEMISTRY

Molecular and pharmacological characterization of insulin icodec: a new basal insulin analog designed for once-weekly dosing

(2021) Erica Nishimura et al.   BMJ Open Diabetes Research & Care

Effectiveness of dulaglutide vs liraglutide and exenatide once-weekly. A real-world study and meta-analysis of observational studies

(2020) Mario Luca Morieri et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

237-OR: Insulin Icodec: An Insulin Analog Suited for Once-Weekly Dosing in Type 2 Diabetes

(2020) ULRIKE HÖVELMANN et al.   DIABETES

Once-Weekly Insulin for Type 2 Diabetes without Previous Insulin Treatment

(2020) Julio Rosenstock et al.   NEW ENGLAND JOURNAL OF MEDICINE

Engineering of Orally Available, Ultralong-Acting Insulin Analogues: Discovery of OI338 and OI320

(2020) Thomas B. Kjeldsen et al.   JOURNAL OF MEDICINAL CHEMISTRY

Efficacy and safety of oral basal insulin versus subcutaneous insulin glargine in type 2 diabetes: a randomised, double-blind, phase 2 trial

(2019) Inge B Halberg et al.   Lancet Diabetes & Endocrinology

New Insulin Glargine 300 units{middle dot}mL-1 Provides a More Even Activity Profile and Prolonged Glycemic Control at Steady State Compared With Insulin Glargine 100 units{middle dot}mL-1

(2014) R. H. A. Becker et al.   DIABETES CARE

Insulin degludec: overview of a novel ultra long-acting basal insulin

(2012) S. C. L. Gough et al.   DIABETES OBESITY & METABOLISM

A 24-Week, Randomized, Treat-to-Target Trial Comparing Initiation of Insulin Glargine Once-Daily With Insulin Detemir Twice-Daily in Patients With Type 2 Diabetes Inadequately Controlled on Oral Glucose-Lowering Drugs

(2010) S. G. Swinnen et al.   DIABETES CARE

Patient perspectives on once-weekly medications for diabetes

(2010) W. H. Polonsky et al.   DIABETES OBESITY & METABOLISM

Identification of High Affinity Fatty Acid Binding Sites on Human Serum Albumin by MM-PBSA Method

(2007) Shin-ichi Fujiwara et al.   BIOPHYSICAL JOURNAL